FDA Warns of Increased Risk of Suicidal Thoughts from Drugs Used to Treat Epilepsy, Migraines and Bipolar Disorder

At the end of January, the FDA issued a press release warning health care professionals about an increased risk of suicidal thoughts and behaviors (suicidality) in patients who take drugs called antiepileptics to treat epilepsy, bipolar disorder, migraine headaches, and other conditions.

The FDA advised patients who are currently taking antiepileptic medicines not to make any changes without first talking to their health care provider. Health care providers should notify patients, their families, and caregivers of the potential for an increase in the risk of suicidal thoughts or behaviors so that patients may be closely observed for notable changes in behavior.

Click here for the full release.

The Oregon and Washington medication error lawyers at D’Amore & Associates assist clients who have been injured due to dangerous side effects from drugs.